317 related articles for article (PubMed ID: 7859743)
1. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V
EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743
[TBL] [Abstract][Full Text] [Related]
2. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V
AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
5. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.
Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M
AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
[TBL] [Abstract][Full Text] [Related]
7. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
8. Characterization of free radical defense system in high glucose cultured HeLa-tat cells: consequences for glucose-induced cytotoxicity.
Bouvard S; Faure P; Roucard C; Favier A; Halimi S
Free Radic Res; 2002 Sep; 36(9):1017-22. PubMed ID: 12448827
[TBL] [Abstract][Full Text] [Related]
9. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.
Flores SC; Marecki JC; Harper KP; Bose SK; Nelson SK; McCord JM
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7632-6. PubMed ID: 8395050
[TBL] [Abstract][Full Text] [Related]
10. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation.
Richard MJ; Guiraud P; Didier C; Seve M; Flores SC; Favier A
Arch Biochem Biophys; 2001 Feb; 386(2):213-20. PubMed ID: 11368344
[TBL] [Abstract][Full Text] [Related]
13. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
Cheng H; Tarnok J; Parks WP
J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
[TBL] [Abstract][Full Text] [Related]
15. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.
Alcamí J; Laín de Lera T; Folgueira L; Pedraza MA; Jacqué JM; Bachelerie F; Noriega AR; Hay RT; Harrich D; Gaynor RB
EMBO J; 1995 Apr; 14(7):1552-60. PubMed ID: 7729429
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
18. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
Demarchi F; d'Adda di Fagagna F; Falaschi A; Giacca M
J Virol; 1996 Jul; 70(7):4427-37. PubMed ID: 8676466
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
Su Y; Popik W; Pitha PM
J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
[TBL] [Abstract][Full Text] [Related]
20. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
